Related Experiment Video
Updated: May 14, 2026

Investigating Aortic Valve Calcification via Isolation and Culture of T Lymphocytes using Feeder Cells from Irradiated Buffy Coat
Published on: February 4, 2021
Aortic valve sclerosis is a high predictive marker of systemic endothelial dysfunction in hypertensive patients
T Erdoğan1, M Cetin, S A Kocaman
1Department of Cardiology, Rize University Medical Faculty, Rize, Turkey.
Insights
Aortic valve sclerosis in hypertensive patients is independently predicted by age and endothelial dysfunction. Aortic valve sclerosis presence in hypertension predicts endothelial dysfunction, prompting aggressive risk factor modification.
Area of Science:
- Cardiology
- Vascular Biology
- Hypertension Research
Background:
- Aortic valve sclerosis (AVS) is linked to hypertension and predicts cardiovascular events.
- Mechanisms underlying AVS development remain unclear.
- Investigating atherosclerosis risk factors in untreated hypertensive patients is crucial.
Purpose of the Study:
- To explore the influence of atherosclerosis-related risk factors on AVS in untreated hypertensive patients.
- To identify independent predictors of AVS in this population.
- To assess the relationship between AVS and endothelial dysfunction.
Main Methods:
- Cross-sectional observational study of 107 untreated hypertensive patients.
- Vascular evaluation including carotid intima-media thickness (CIMT), pulse wave velocity (PWV), and flow-mediated dilation (FMD%).
- Echocardiographic assessment and analysis of risk factors like epicardial adipose tissue (EAT).
Main Results:
- Univariate analysis showed associations between AVS and age, male sex, waist circumference, EAT, smoking, FMD%, CIMT, and carotid plaque.
- Multivariate analysis identified age and FMD% as independent predictors of AVS.
- AVS presence predicted endothelial dysfunction with a high positive predictive value (100%).
Conclusions:
- Systemic endothelial dysfunction plays an initial and independent role in AVS pathogenesis.
- AVS in hypertensive patients is a significant predictor of endothelial dysfunction.
- Clinicians should consider aggressive risk factor modification for hypertensive patients with AVS.
Background:
Aortic valve sclerosis (AVS) is closely related to hypertension and is an important predictor of coronary artery disease as well as cardiovascular morbidity and mortality. However, the mechanisms causing AVS have not yet been clarified. Therefore, we planned to investigate the influence of atherosclerosis-related risk factors including C-reactive protein (CRP), epicardial adipose tissue (EAT), carotid intima-media thickness (CIMT), pulse wave velocity (PWV), left ventricular hypertrophy, and the conventional risk parameters as well as endothelial dysfunction in untreated hypertensive patients.
Methods And Results:
Our study was cross-sectional and observational, and included 107 consecutive untreated hypertensive patients. All patients underwent vascular evaluation by CIMT, PWV, flow-mediated dilation (FMD%), as well as echocardiographic examinations. Age (OR = 1.180, p < 0.001), male sex (OR = 3.056, p = 0.019), waist circumference (OR = 1.082, p = 0.004), EAT (OR = 1.419, p = 0.001), smoking status (OR = 3.161, p = 0.014), FMD% (OR = 0.649, p < 0.001), mean CIMT (OR = 2.481, P < 0.001), and carotid plaque (OR = 4.692, P = 0.001) were associated with AVS in univariate analyses. Multivariate analyses revealed only age (OR = 1.144, P = 0.006) and FMD% (OR = 0.691, 0.001) as independent predictors of AVS. The presence of AVS had a high positive predictive value (100 %) but a low negative predictive value (51 %) for endothelial dysfunction (FMD < 12 %) in hypertensive patients.
Conclusion:
Our study supports the theory that systemic endothelial dysfunction has an initial and independent effect on AVS pathogenesis. Moreover, we demonstrated that the presence of AVS in patients with hypertension predicts endothelial dysfunction, with a high positive predictive value. Thus, AVS in hypertensive patients may urge clinicians toward aggressive risk factor modification and intensive treatment.
Related Concept Videos
Aortic Regurgitation II: Clinical Features and Diagnostic Tests
Mitral Stenosis I: Introduction
Aortic Regurgitation I: Introduction
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
Heart Failure II: Pathophysiology
Aortic Regurgitation III: Medical Management
